Angioplasty with drug-coated balloon catheters: the coming tide?
作者信息
Byrne Robert A, Durand Rory
机构信息
Cardiovascular Research Institute Dublin, and Department of Cardiology, Mater Private Network, Dublin, Ireland.
School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
出版信息
EuroIntervention. 2024 Jul 1;20(13):e786-e788. doi: 10.4244/EIJ-E-24-00035.
Abstract
摘要
相似文献
1
Angioplasty with drug-coated balloon catheters: the coming tide?药物涂层球囊导管血管成形术：即将到来的潮流？
EuroIntervention. 2024 Jul 1;20(13):e786-e788. doi: 10.4244/EIJ-E-24-00035.
2
Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).紫杉醇涂层球囊与球囊血管成形术治疗的长期结果：PEPCAD-DES 研究的见解（使用 SeQuent Please 紫杉醇涂层经皮腔内冠状动脉血管成形术 [PTCA] 导管治疗药物洗脱支架 [DES] 支架内再狭窄）。
JACC Cardiovasc Interv. 2015 Nov;8(13):1695-700. doi: 10.1016/j.jcin.2015.07.023.
3
Drug-Coated Balloons Versus Drug-Eluting Stents or Plain Old Balloon Angioplasty: A Long-Term in-Stent Restenosis Study.药物涂层球囊与药物洗脱支架或普通球囊血管成形术：一项关于支架内再狭窄的长期研究
J Am Heart Assoc. 2024 Dec 3;13(23):e036839. doi: 10.1161/JAHA.124.036839. Epub 2024 Nov 22.
4
Drug-Coated Balloons for Percutaneous Coronary Intervention: Does Coating Matter?用于经皮冠状动脉介入治疗的药物涂层球囊：涂层重要吗？
JACC Cardiovasc Interv. 2024 Jul 8;17(13):1544-1546. doi: 10.1016/j.jcin.2024.05.015.
5
Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.药物涂层球囊与球囊血管成形术治疗后药物洗脱支架再狭窄的血管造影模式：PEPCAD-DES研究的晚期管腔丢失亚组分析
Catheter Cardiovasc Interv. 2016 Oct;88(4):529-534. doi: 10.1002/ccd.26451. Epub 2016 Feb 19.
6
Intravascular Ultrasound Guides Drug-Coated Balloon Angioplasty Toward Better Angiographic Outcomes-But How?血管内超声引导药物涂层球囊血管成形术实现更好的血管造影结果——但如何实现呢？
JACC Cardiovasc Interv. 2024 Sep 23;17(18):2193. doi: 10.1016/j.jcin.2024.07.019.
7
Reply: Intravascular Ultrasound Guides Drug-Coated Balloon Angioplasty Toward Better Angiographic Outcomes-But How?回复：血管内超声引导药物涂层球囊血管成形术以获得更好的血管造影结果——但如何做到呢？
JACC Cardiovasc Interv. 2024 Sep 23;17(18):2194. doi: 10.1016/j.jcin.2024.08.001.
8
Comparing the Efficacy of Sirolimus and Paclitaxel-Eluting Balloon Catheters in the Treatment of Coronary In-Stent Restenosis: A Prospective Randomized Study (TIS 2 Study).比较西罗莫司与紫杉醇洗脱球囊导管治疗冠状动脉支架内再狭窄的疗效：一项前瞻性随机研究（TIS 2研究）。
Circ Cardiovasc Interv. 2025 May;18(5):e014677. doi: 10.1161/CIRCINTERVENTIONS.124.014677. Epub 2025 Apr 2.
9
Drug-coated balloons: Back to the future? What should we learn from the past?药物涂层球囊：回到未来？我们应从过去吸取什么教训？
Cardiovasc Revasc Med. 2024 Sep;66:76-77. doi: 10.1016/j.carrev.2024.07.001. Epub 2024 Jul 4.
10
Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial.药物洗脱支架内再狭窄患者应用切割球囊及药物涂层球囊治疗的新生内膜改变：一项随机对照试验
JACC Cardiovasc Interv. 2017 Jul 10;10(13):1332-1340. doi: 10.1016/j.jcin.2017.04.024.
本文引用的文献
1
Biolimus-coated versus paclitaxel-coated balloons for coronary in-stent restenosis (BIO ASCEND ISR): a randomised, non-inferiority trial.载比伐卢定涂层球囊与紫杉醇涂层球囊治疗冠状动脉支架内再狭窄（BIO ASCEND ISR）：一项随机、非劣效性试验。
EuroIntervention. 2024 Jul 1;20(13):e806-e817. doi: 10.4244/EIJ-D-24-00295.
2
Paclitaxel-Coated Balloon vs Uncoated Balloon for Coronary In-Stent Restenosis: The AGENT IDE Randomized Clinical Trial.紫杉醇涂层球囊与非涂层球囊治疗冠状动脉支架内再狭窄的比较：AGENT IDE 随机临床试验。
JAMA. 2024 Mar 26;331(12):1015-1024. doi: 10.1001/jama.2024.1361.
3
Sirolimus-Coated Balloon Angioplasty for Coronary Artery Disease: One Step Forward, Two Steps Back.西罗莫司涂层球囊血管成形术治疗冠状动脉疾病：前进一步，后退两步。
JACC Cardiovasc Interv. 2023 Dec 11;16(23):2897-2899. doi: 10.1016/j.jcin.2023.11.010.
4
A Prospective Randomized Trial Comparing Sirolimus-Coated Balloon With Paclitaxel-Coated Balloon in De Novo Small Vessels.在新发小血管中比较西罗莫司涂层球囊与紫杉醇涂层球囊的前瞻性随机试验
JACC Cardiovasc Interv. 2023 Dec 11;16(23):2884-2896. doi: 10.1016/j.jcin.2023.09.026. Epub 2023 Oct 23.
5
Quality and transparency of evidence for implantable cardiovascular medical devices assessed by the CORE-MD consortium.COREMDS 联盟评估的心血管植入医疗器械的证据质量和透明度。
Eur Heart J. 2024 Jan 14;45(3):161-177. doi: 10.1093/eurheartj/ehad567.
6
Comparing a strategy of sirolimus-eluting balloon treatment to drug-eluting stent implantation in de novo coronary lesions in all-comers: Design and rationale of the SELUTION DeNovo Trial.比较所有患者中初次冠状动脉病变中应用西罗莫司洗脱球囊治疗与药物洗脱支架植入的策略：SELUTION DeNovo 试验的设计和原理。
Am Heart J. 2023 Apr;258:77-84. doi: 10.1016/j.ahj.2023.01.007. Epub 2023 Jan 13.
7
Combined Analysis of Two Parallel Randomized Trials of Sirolimus-Coated and Paclitaxel-Coated Balloons in Coronary In-Stent Restenosis Lesions.两种药物涂层球囊治疗冠状动脉支架内再狭窄病变的平行随机对照试验联合分析。
Circ Cardiovasc Interv. 2022 Sep;15(9):e012305. doi: 10.1161/CIRCINTERVENTIONS.122.012305. Epub 2022 Sep 20.
8
Biolimus-Coated Balloon in Small-Vessel Coronary Artery Disease: The BIO-RISE CHINA Study.载有比伐卢定的球囊在小血管病变中的应用：BIO-RISE CHINA 研究
JACC Cardiovasc Interv. 2022 Jun 27;15(12):1219-1226. doi: 10.1016/j.jcin.2022.03.024. Epub 2022 May 25.
9
Management of in-stent restenosis.支架内再狭窄的处理。
EuroIntervention. 2022 Jun 3;18(2):e103-e123. doi: 10.4244/EIJ-D-21-01034.
10
Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis: a comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study).紫杉醇涂层球囊血管成形术与药物洗脱支架治疗冠状动脉支架内再狭窄的比较：10项随机临床试验的综合、协作、个体患者数据荟萃分析（代达罗斯研究）
Eur Heart J. 2020 Oct 7;41(38):3715-3728. doi: 10.1093/eurheartj/ehz594.
Zotero 插件